Thus, our work highlighted the significant role of BANCR-mediated inhibition of G6PD activity in regulating ccRCC tumorigenesis and suggested its potential as a therapeutic target for ccRCC. This evidence concerns the gene G6PD and nonpapillary renal cell carcinoma.